<b><i>ITPA</i></b> and <b><i>SLC29A1</i></b> Genotyping for the Prediction of Ribavirin Dose Reduction in Anti-HCV Triple Therapy with Protease InhibitorsAndrea Lombardi, Felicia Stefania Falvella, Cristina Mazzali et al.|Pharmacology|2015Cited by 2
P1168 ITPA AND SLC29A1 GENOTYPING BEFORE TRIPLE THERAPY PREDICT SEVERITY OF RIBAVIRIN-INDUCED ANEMIALaura Milazzo, Felicia Stefania Falvella, Simona Landonio et al.|Journal of Hepatology|2014Cited by 0